168 related articles for article (PubMed ID: 11563932)
1. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
Antonini I; Polucci P; Magnano A; Martelli S
J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
[TBL] [Abstract][Full Text] [Related]
2. 2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2002 Jan; 45(3):696-702. PubMed ID: 11806721
[TBL] [Abstract][Full Text] [Related]
3. N4-(omega-Aminoalkyl)-1-[(omega-aminoalkyl)amino]-4- acridinecarboxamides: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Kelland LR; Spinelli S; Pescalli N; Martelli S
J Med Chem; 2000 Dec; 43(25):4801-5. PubMed ID: 11123989
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
6. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
[TBL] [Abstract][Full Text] [Related]
7. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
8. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.
Antonini I; Polucci P; Magnano A; Cacciamani D; Konieczny MT; Paradziej-Łukowicz J; Martelli S
Bioorg Med Chem; 2003 Feb; 11(3):399-405. PubMed ID: 12517435
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
10. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
[TBL] [Abstract][Full Text] [Related]
11. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs.
Antonini I; Santoni G; Lucciarini R; Amantini C; Sparapani S; Magnano A
J Med Chem; 2006 Nov; 49(24):7198-207. PubMed ID: 17125272
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidoacridine derivatives as potential antitumor agents.
Antonini I; Cola D; Martelli S; Cholody WM; Konopa J
Farmaco; 1992; 47(7-8):1035-46. PubMed ID: 1445611
[TBL] [Abstract][Full Text] [Related]
14. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
[TBL] [Abstract][Full Text] [Related]
15. Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation.
Rastogi K; Chang JY; Pan WY; Chen CH; Chou TC; Chen LT; Su TL
J Med Chem; 2002 Sep; 45(20):4485-93. PubMed ID: 12238927
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of phenanthrene-derived carboxamides as cytotoxic agents.
Cherubim P; Deady LW; Dorkos M; Quazi NH; Baguley BC; Denny WA
Anticancer Drug Des; 1993 Dec; 8(6):429-38. PubMed ID: 8286011
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
18. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of conjugates of muramyldipeptide, normuramyldipeptide, and desmuramylpeptides with acridine/acridone derivatives.
Dzierzbicka K; Kołodziejczyk AM; Wysocka-Skrzela B; Myśliwski A; Sosnowska D
J Med Chem; 2001 Oct; 44(22):3606-15. PubMed ID: 11606125
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]